Show simple item record

dc.contributor.authorWhite, Terranceen_US
dc.date.accessioned2011-08-16T14:32:40Z
dc.date.available2011-08-16T14:32:40Z
dc.date.issued2011-08-04
dc.identifier.urihttp://hdl.handle.net/1853/40590
dc.descriptionRavi Bellamkonda Laben_US
dc.descriptionPresented on August 4, 2011 from 9:00 am to 11:30 am in room 1107 of the Parker H. Parker Petit Institute for Bioengineering and Bioscience.en_US
dc.descriptionRuntime: 16:43 minutesen_US
dc.description.abstractCancer has become a major topic of research in the search to find a cure that is effective. Described as a group of diseases that are characterized by the uncontrollable growth of cells, cancer is known to be the second major leading cause of death in the world behind heart disease. There are many therapeutic treatments for cancer such as surgery, chemotherapy, immunotherapy and radiation. However, a major concern arises when there are apparent side effects from such treatments. Therefore, targeted therapy, which utilizes nanoparticles to deliver drugs directly to the tumor region by way of the enhanced permeability and retention effect, has become an area of interest. The Bellamkonda Lab at Georgia Institute of Technology focuses on liposomal nanoparticles to deliver an anti brain tumor drug, Imipramine blue, directly to tumor sites. There have been many laboratory investigations concerning the toxicity and effectiveness of the Imipramine blue liposomes. As a result, they have proven to yield adequate results by inhibiting the growth of tumor cells and prolonging the Imipramine blue life span in the blood stream.en_US
dc.format.extent16:43 minutesen_US
dc.language.isoen_USen_US
dc.publisherGeorgia Institute of Technologyen_US
dc.subjectTargeted cancer therapyen_US
dc.titleTargeted Cancer Therapy: An application of Impramine Blue (IB) Lipsomes in Cancer Treatmenten_US
dc.typePresentationen_US
dc.typeVideoen_US
dc.contributor.corporatenameGeorgia Institute of Technology. Emergent Behavior of Integrated Cellular Systemsen_US
dc.contributor.corporatenameGeorgia Institute of Technology. Dept. of Biomedical Engineeringen_US
dc.contributor.corporatenameEmory University. Dept. of Biomedical Engineeringen_US
dc.description.advisorBalakrishna Pai-Mentoren_US


Files in this item

This item appears in the following Collection(s)

Show simple item record